Kang Li,Wang Haixia,Liu Guiming,Bao Tianhao,Treatment progress of weight gain and abnormal lipid metabolism in patients with schizophrenia caused by clozapine and olanzapine[J].SICHUAN MENTAL HEALTH,2021,34(2):182-186
Treatment progress of weight gain and abnormal lipid metabolism in patients with schizophrenia caused by clozapine and olanzapine
DOI:10.11886/scjsws20201214001
English keywords:Clozapine  Olanzapine  Abnormal lipid metabolism  Weight gain  Treatment
Fund projects:春城计划昆明青年拔尖人才项目(项目名称:基于经颅磁刺激对精神分裂症临床诊疗策略的创新研究,项目编号:2018-03-09-004);云南省科技厅昆明医科大学应用基础研究联合专项资金面上项目(项目名称:自主运动介导miR-103-3p/BDNF通路改善精神分裂症认知功能的机制研究,项目编号:2018FE001(-223);项目名称:miR-124/TCF4轴在氯氮平抑制精神分裂症小鼠海马组织细胞凋亡过程中的机制研究,项目编号:2019FE001(-107))
Author NameAffiliationPostcode
Kang Li Kunming Medical University Affiliated Mental Health Center Psychiatric Hospital of Yunnan Province Kunming 650224 China 650224
Wang Haixia Kunming Medical University Affiliated Mental Health Center Psychiatric Hospital of Yunnan Province Kunming 650224 China 650224
Liu Guiming Kunming Medical University Affiliated Mental Health Center Psychiatric Hospital of Yunnan Province Kunming 650224 China 650224
Bao Tianhao Kunming Medical University Affiliated Mental Health Center Psychiatric Hospital of Yunnan Province Kunming 650224 China 650224
Hits:
Download times:
English abstract:
      To address the issue of weight gain and abnormal lipid metabolism caused by clozapine and olanzapine administration in patients with schizophrenia, a qualitative and systematic review was carried out, thus providing references for clinical treatment and future research. This review embraces the aspects of pharmacotherapy, traditional Chinese medicine treatment and so on.
View Full Text   View/Add Comment  Download reader
Close